ArticleJournal of nanobiotechnology2022

Neutrophil membrane engineered HucMSC sEVs alleviate cisplatin-induced AKI by enhancing cellular uptake and targeting.

Peipei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.